Pexelizumab does not "complement" percutaneous coronary intervention in patients with ST-elevation myocardial infarction

JAMA. 2007 Jan 3;297(1):91-2. doi: 10.1001/jama.297.1.91.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Angioplasty, Balloon, Coronary*
  • Anti-Inflammatory Agents / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Humans
  • Myocardial Infarction / therapy*
  • Single-Chain Antibodies

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Single-Chain Antibodies
  • pexelizumab